Reconsideration of Secondary Risk Management Strategies in Patients with Ischemic Heart Disease.
The main risk factors in ischemic heart diseases, including myocardial infarction, are hypertension, dyslipidemia, diabetes, obesity and smoking. The incidence of ischemic heart disease in Japan has been lower than that in Western countries because of differences in lifestyle and the anatomy of the coronary arteries, but the situation has been changing recently because of the westernization of lifestyle. Cardiovascular diseases have become the second most common cause of death in Japan, and 40% of those deaths are attributed to ischemic heart disease. Patients with a history of myocardial infarction, especially, have an increased risk of re-infarction, so strict management of coronary risk factors is important for the prevention of secondary ischemic heart disease. Although there are many guidelines about how to manage the risk factors, there are still many problems. Although lipid management has been demonstrated to have a protective effect against coronary artery disease and arteriosclerotic guidelines have been developed, it is reported that only about one third of patients achieved the low-density lipoprotein (LDL) target value under secondary prevention. Moreover, it is unclear whether the lower target value is required for high-risk patients. Recent research on diabetes has reported increased mortality in patients with intensive glycemic control. We should discuss when to start treatment, which medicine to use, and to what extent we should manage glycemic control. Strict management based on current therapeutic guidelines is effective for secondary prevention of ischemic heart disease, with target values of less than 135/85 mmHg for home blood pressure, less than 100 mg/dl for LDL-C, more than 40 mg/dl for HDL-C, less than 150 mg/dl for TG, and, for diabetic patients, less than 7.0% for HbA1c (NGSP).
Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
Kuninobu
K
Kashiyama
Shinjo
S
Sonoda
Yutaka
Y
Otsuji
D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D017202:Myocardial Ischemia / Q000209:etiology* / Q000517:prevention & control*; D009765:Obesity / Q000150:complications; D017410:Practice Guidelines as Topic; D051436:Renal Insufficiency, Chronic / Q000150:complications; D012307:Risk Factors; D012308:Risk Management; D055502:Secondary Prevention; D012907:Smoking / Q000009:adverse effects